(Q36659848)

15 August 2017

1 reference

title

New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors (English)

1 reference

15 August 2017

0 references

0 references

0 references

Jürg Gertsch

1

1 reference

PubMed ID

17118807

15 August 2017

Stefan Raduner

series ordinal

2

1 reference

PubMed ID

17118807

15 August 2017

Karl-Heinz Altmann

series ordinal

3

1 reference

15 August 2017

1 January 2006

1 reference

Journal of Receptors and Signal Transduction

15 August 2017

1 reference

15 August 2017

26

1 reference

15 August 2017

5-6

1 reference

15 August 2017

709-730

1 reference

The cannabinoid receptor: biochemical, anatomical and behavioral characterization

15 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Endocannabinoid metabolic pathways and enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

The cannabinoid system and immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Further advances in the synthesis of endocannabinoid-related ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid receptors as therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

The endocannabinoid system and its therapeutic exploitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid receptor as a novel target for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

An endocannabinoid mechanism for stress-induced analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

CB2 cannabinoid receptor mediation of antinociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Peripheral cannabinoid receptor, CB2, regulates bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid receptor type 2 gene is associated with human osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Alkamides isolated from plants promote growth and alter root development in Arabidopsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Fungistatic and bacteriostatic activities of alkamides from Heliopsis longipes roots: affinin and reduced amides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Rapid biosynthesis of N-linolenoyl-L-glutamine, an elicitor of plant volatiles, by membrane-associated enzyme(s) in Manduca sexta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

N-Acylethanolamines in seeds. Quantification Of molecular species and their degradation upon imbibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Trick or treat from food endocannabinoids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Alkylamides that produce tingling paresthesia activate tactile and thermal trigeminal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Macrophage activating effects of new alkamides from the roots of Echinacea species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

Cannabinoid-based drugs as anti-inflammatory therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10799890600942674

10.1080/10799890600942674

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17118807